Skip to main content
. 2012 Sep;14(9):788–798. doi: 10.1593/neo.12526

Table 2.

Comparison of Tumor Location, Patient Age, and Recurrent Copy Number Alterations in Copy Number Studies of Chordomas.

Study Diaz et al. (this study) Le et al. [33] Hallor et al. [12] Scheil et al. [19]
Total number of tumors 22 20 26 16
Location
Clivus 21 2 0 5
Mobile spine 1 7 2 1
Sacrum 0 11 24* 10
Primary samples 19 17 18 7
Median age (years) 38 61.5 60 61
Platform Affymetrix 500K Agilent 250K BAC array CGH CGH
Broad significance copy number changes (frequency)
Gains 1q21.1-q25.2; 1q31.3-q43
5p15.33; 5q31.1-q31.2; 5q35.1-q35.3 5q (0.38)
6q25.3-q27
7 (0.68) 7p36.3-p22.3 (0.25) 7 7q (0.69)
8q24.3 (0.35) 8q24.21-q24.22
11q12.2-q13.4 (0.30)
12p13.33-p12.1; 12q13.11-q13.13 12q (0.38)
15q11.2
16q21-q22.2
17q11.1-q25.3 (0.25)
19p (0.55); 19q (0.55) 19p13.3-q13.43 (0.30) 19p13.3-p13.2; 19q12-q13.43
20q11.21-q13.12; 20q13.33 20 (0.50)
Losses 1p36.33-p11.1 1p (0.44)
2q34-q37.3
3 (0.45) 3p29-p26.3 (0.75) 3 3p (0.5)
4p16.3-q35.2 (0.40) 4
6q21-q22.33 (0.25) 6p21.1
7q11.22-q11.23
8p12-p11.1
9p24.3-q34.3 (0.25) 9p24.3-q31.3; 9q33.3-q34.3
10p (0.61); 10q (0.57) 10p15.3-q26.3 (0.65) 10
11p15.5-p11.12 (0.30) 11p15.5-p15.3; 11p14.3-p11.2; 11q12.2-q13.2; 11q14.3-q25
12p11.21-p11.1; 12q24.31
13q (0.61) 13q11-q34 (0.60) 13
14q (0.65) 14q11.1-q32.33 (0.65) 14
15q11.2; 15q15.1-q21.1
16p13.3; 16p12.3-q24.3
17p13.3-p11.1 (0.35) 17p13.3-p11.1; 17q25.1-q21.3
18p11.32-q23 (0.40) 18
19p13.3-p11
19q13.11-q13.43
20p11.21-q11.21
22q (0.71) 22q11.1-q13.33 (0.45)
21q22.2-q22.3
Xp22.33
Yp11.2; Yq11.22-q11.23
*

Includes 4 coccyx chordomas and 20 sacral chordomas.

All four studies differ in the reporting of significant broad copy number alterations. We use z-scores of >2 or <0.5 and q-values < 0.05 regardless of frequency. Long et al. list copy changes occurring in >25% of cases. Hallor et al. report copy changes occurring in greater than or equal to five cases with individual frequencies not provided. Scheil et al. reports the most frequent gains and losses.